Showing results (2401-2410 of 2,466) with videos related to
Sort By:
Pageof 247
Therapie|March 1, 1997
[Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders]J P Blayac, D Hillaire-Buys, H PeyrièreTherapie|March 1, 1997
[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary]M Auriche, P Bertrand, N Blay, et al.Therapie|March 1, 1997
[Mycophenolate mofetil, a new immunosuppressive agent. Is pharmacokinetic monitoring justified?]J Barré, N Simon, J P TillementTherapie|March 1, 1997
[Apropos of recent antidepressant drugs: some pharmacological comments]J L Montastruc, J M Sénard, M Lapeyre-MestreTherapie|November 5, 2005
The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugsMuriel Vray, Bernard Hamelin, Patrice Jaillon, et al.Therapie|November 5, 2005
Methodology for the evaluation and measurement of therapeutic progressDidier Guillemot, Georges France, Pierre Fender, et al.Therapie|November 5, 2005
[Clinical trials using medicinal plants: bibliographical review and methodological analysis]Mamadou Kamagaté, Henri Die-Kacou, Eric Balayssac, et al.Therapie|September 11, 2018
[Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database]Sylvie Favrelière, Claire Lafay-Chebassier, Bernard Fauconneau, et al.Therapie|September 4, 2018
[Drug-induced vasculitis]Neila Fathallah, Bouraoui Ouni, Sana Mokni, et al.Therapie|May 3, 2017
Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problemsJeffrey K AronsonPageof 247